Request for Applications
The CMCR seeks to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts.
Read More.
CMCR studies
Current studies examine the effects of cannabis and cannabinoids on a range of psychiatric, developmental and pain conditions, as well as the impact of use on public safety (e.g., driving). A list of current and past studies can be found here.
CMCR Symposium
Planning is currently underway for the CMCR Symposium for Fall 2021. Please check back for updates. Information on the CMCR symposium series, including archives of previous meetings, can be found here.
- All
- Announcements
- Current Studies
- Information
- News
- Presentations
- Publications
- Studies
- Symposia
- Default
- Title
- Date
- Random
-
John Watson, Medscape, January 5, 2021 Dr. Mark Wallace spoke to Medscape about cannabis treatment for pain management and other…Read More -
Part of the CMCR mission is to foster the careers of future generations of basic and clinical scientists who will…Read More -
Dr. Igor Grant presented at Penn State College of Medicine's Psychiatry and Behavioral Health Grand Rounds on January 28, 2021.…Read More -
Citing the work of the Center for Medicinal Cannabis Research, Representative Scott Peters made remarks in support of the Medical…Read More -
In November 2020, the California Bureau of Cannabis Control (BCC) announced the recipients for its public university research grants program.…Read More -
Dr. Igor Grant discusses cognitive effects of cannabis use and current cannabis research on the Navigating Neuropsychology (NavNeuro) podcast. Hosts…Read More -
Scott LaFee, UC San Diego Health Newsroom, July 14, 2020 Researchers at UC San Diego's Center for Medicinal Cannabis Research…Read More -
CMCR Director Igor Grant congratulates Donald Abrams, MD, of UCSF on his retirement, and highlights some key contributions Dr. Abrams…Read More -
Marilynn Larkin, Reuters Health, April 30, 2020 In a recently published paper, Ron Ellis and colleagues found that cannabis may…Read More -
Shalina Chatlani, KPBS, December 19, 2019 More people are buying marijuana since California legalized its retail sale two years ago.…Read More -
Alicia Wallace, CNN Business, January 2, 2020 As a growing number of states legalize cannabis, health officials are increasingly sounding…Read More -
Congratulations to Dr. Marsida Kallupi, Assistant Professor in the Department of Psychiatry at UC San Diego, for being selected for…Read More -
Emily Land, San Francisco AIDS Foundation, February 24, 2020 In a recently published paper, Caitlin Wei-Ming Watson and CMCR colleagues…Read More -
Study results show that cannabis may have a beneficial impact on HIV-associated blood brain barrier injury.Read More -
Shalina Chatlani, KPBS, December 20, 2019 Marijuana is hard to police. A small amount may significantly impair a novice user…Read More -
Ashleigh Papp, San Jose Mercury News, January 2, 2020 Scientists must obtain hard-to-get license from DEA in order to conduct…Read More -
Dr. Igor Grant presented at the University of Texas at Dallas's Center for BrainHealth lecture series - The Brain: An Owner's…Read More -
Findings suggest cannabis exposure is linked to a lower odds of neurocognitive impairment in the context of HIV. A possible…Read More
-
Scott LaFee, UC San Diego News Center, October 10, 2019 The Center for Medicinal Cannabis Research (CMCR) at University of…Read More -
Information and materials for this event are available from the FDA at: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds May 31, 2019 Erika Edwards previewed the…Read More
load more
hold SHIFT key to load all
load all